The Food and Drug Administration has approved a topical anticholinergic, sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis in adults and children aged ≥ 9 years.

Excessive sweating of the face and head can be both uncomfortable and socially challenging. Normally, sweating helps regulate body temperature, cooling the body during heat, exercise, or stress.